Acquired Angioedema

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
Status:
Completed
Last Changed:
May 4, 2009
First Changed:
Jul 13, 2005
Disease(s):
Hereditary Angioedema Type I
Intervention(s):
C1 inhibitor concentrate
C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Status:
Completed
Last Changed:
May 4, 2009
First Changed:
Jul 29, 2005
Disease(s):
Angioedema
Intervention(s):
C1 inhibitor concentrate (C1-esteraseremmer-N)

Connect. Empower. Inspire.